• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Jeffrey Brenner Is Leaving UnitedHealth To Return To Primary Care Roots


Founder of the Camden Coalition and a SDOH pioneer is looking to establish a primary care clinic in southern New Jersey.

Jeffrey Brenner, M.D., who has pioneered programs for vulnerable populations and high utilizers of health care, has left his position at UnitedHealth Group to open up a primary care clinic in southern New Jersey.

“I'm going to do a primary care startup,” he said during a telephone interview today with Managed Healthcare Executive.® “I'm a family doc, and my true love has always been primary care.”

Brenner, 51, said he has been looking for office space the past few days. UnitedHealth Group has announced his departure internally, but there has been no external announcement.

Brenner was hired by UnitedHealth in February 2017 after he founded the Camden Coalition of Healthcare Providers in 2003. Brenner and the coalition took the then-novel approach of identifying people who went to emergency departments often and were high — and expensive — utilizers of heath care. The group offered preventive services, including some outside of the normal boundaries healthcare, to address their illnesses and reduce their use of healthcare services and the associated expenditure.

Kathleen Stillo

Kathleen Stillo

Brenner and the coalition’s efforts are partly responsible for the current focus on addressing the social determinants of health. Atul Gawande, M.D., wrote a profile of Brenner and the coalition for The New Yorker in 2011 titled "The Hot Spotters." In 2013, Brenner was awarded a MacArthur “Genius” Grant.

At UnitedHealth, Brenner led the creation of programs in over a dozen cities that provide housing and other non-medical services to vulnerable populations covered by the country’s largest insurer.

Brenner said he is planning to return to his roots as a family physician beginning sometime this fall. He said he will be working with Kathleen Stillo, MBA, who worked with him in Camden and at UnitedHealth Group, where she was president and chief operating officer for clinical redesign.

Brenner and Stillo ran a “pandemic hotel” in Secaucus, New Jersey, for COVID-19 patients earlier this year. The site was set up to temporarily separate patients from their families in an effort to stop the spread of the deadly virus. “In that setting, it was really nice to be back close to frontline care again,” Brenner said.

Related Videos
Video 8 - "Demographic Differences That Impact Care"
Video 7 - "Gaps in Diabetes Education and Self Efficacy"
Video 6 - "Developing Reimbursement Models for Digital Therapeutics"
Video 5 - "Cost-Effectiveness Metrics Payers Seek for Digital Therapeutics"
Video 2 - "Bridging Care Gaps with Prescription Digital Therapeutics"
Video 1 - "Overview of Prescription Digital Therapeutics and Impact on Clinical Practice"
Video 4 - "Payer Challenges in Evaluating Digital Therapeutics"
Video 3 - "Industry Collaboration in Shaping Digital Therapeutics Standards"
Video 6 - "Key Takeaways and Unmet Needs in Diabetes Treatment"
Video 5 - "Allocation of Investment and Value-Based Arrangements in Diabetes Care "
© 2024 MJH Life Sciences

All rights reserved.